Literature DB >> 204804

Noncontraceptive estrogens and nonfatal myocardial infarction.

H Jick, B Dinan, K J Rothman.   

Abstract

We obtained information on 107 women younger than 46 years discharged from a hospital with a diagnosis of acute myocardial infarction. In the series there were 17 women aged 39 to 45 years who were otherwise apparently healthy and had had a natural menopause, hysterectomy, or tubal ligation or whose spouse had had a vasectomy. Among them, nine (53%) were taking noncontraceptive estrogens just prior to admission. Among 34 control women, four (12%) were taking estrogens. The relative risk estimate, comparing estrogen users with nonusers, is 7.5, with 90% confidence limits of 2.4 and 24. All but one of the 17 ml subjects were cigarette smokers. While this illness is rare in most healthy young women, the risk in women older than about 38 years who both smoke and take estrogens appears to be substantial.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 204804

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  11 in total

Review 1.  Hormone replacement therapy and breast cancer, endometrial cancer and cardiovascular disease: risks and benefits.

Authors:  M K Goddard
Journal:  Br J Gen Pract       Date:  1992-03       Impact factor: 5.386

Review 2.  A risk-benefit assessment of estrogen therapy in postmenopausal women.

Authors:  M P Cust; K F Gangar; T C Hillard; M I Whitehead
Journal:  Drug Saf       Date:  1990 Sep-Oct       Impact factor: 5.606

3.  Effects of estrogens and progestins on high density lipoproteins.

Authors:  R M Krauss; F T Lindgren; J Wingerd; D D Bradley; S Ramcharan
Journal:  Lipids       Date:  1979-01       Impact factor: 1.880

4.  The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women.

Authors:  S G Thompson; T W Meade; G Greenberg
Journal:  J Epidemiol Community Health       Date:  1989-06       Impact factor: 3.710

5.  Cyclic hormonal replacement therapy after the menopause: transdermal versus oral treatment.

Authors:  M Cortellaro; T Nencioni; C Boschetti; S Ortolani; F Buzzi; B Francucci; M P Caraceni; P Abelli; F Polvani; C Zanussi
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

6.  Relation between cigarette smoking and use of hormonal replacement therapy for menopausal symptoms.

Authors:  G Greenberg; S G Thompson; T W Meade
Journal:  J Epidemiol Community Health       Date:  1987-03       Impact factor: 3.710

7.  Clinical implications of Surgeon General's Report on Smoking and Health.

Authors: 
Journal:  J Natl Med Assoc       Date:  1979-07       Impact factor: 1.798

Review 8.  Hormone replacement therapy and risk of acute myocardial infarction : a review of the literature.

Authors:  Susan E Bromley; Corinne S de Vries; Dawn Thomas; Richard D T Farmer
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 9.  The risks and benefits of long-term estrogen replacement therapy.

Authors:  E L Barrett-Connor
Journal:  Public Health Rep       Date:  1989 Sep-Oct       Impact factor: 2.792

10.  Postmenopausal oestrogen treatment and stroke: a prospective study.

Authors:  A Paganini-Hill; R K Ross; B E Henderson
Journal:  BMJ       Date:  1988 Aug 20-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.